UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CAR T-cell product performance in haematological malignancies before and after marketing authorisation

The lancet oncology, 2020-02, Vol.21 (2), p.e104-e116

2020

Volltextzugriff (PDF)

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

The Lancet (British edition), 2015-02, Vol.385 (9967), p.517-528

2015

Volltextzugriff (PDF)

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

Blood, 2013-02, Vol.121 (7), p.1165-1174

2013

Volltextzugriff (PDF)

Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor

Molecular therapy, 2022-03, Vol.30 (3), p.1215-1226

2022

Volltextzugriff (PDF)

Immunogenicity of CAR T cells in cancer therapy

Nature reviews. Clinical oncology, 2021-06, Vol.18 (6), p.379-393

2021

Volltextzugriff (PDF)

Immunotoxins for leukemia

Blood, 2014-04, Vol.123 (16), p.2470-2477

2014

Volltextzugriff (PDF)

Characterization of CD22 expression in acute lymphoblastic leukemia

Pediatric blood & cancer, 2015-06, Vol.62 (6), p.964-969

2015

Volltextzugriff (PDF)

Biological roles and potential applications of immune cell-derived extracellular vesicles

Journal of extracellular vesicles, 2017-12, Vol.6 (1), p.1400370-n/a

2017

Volltextzugriff (PDF)

Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells

Journal of extracellular vesicles, 2019-12, Vol.8 (1), p.1588538-n/a

2019

Volltextzugriff (PDF)

Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells

Journal of extracellular vesicles, 2017-12, Vol.6 (1), p.1294368-n/a

2017

Volltextzugriff (PDF)

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

Blood, 2017-10, Vol.130 (14), p.1620-1627

2017

Volltextzugriff (PDF)

Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates

Cancer research (Chicago, Ill.), 2011-10, Vol.71 (20), p.6300-6309

2011

Volltextzugriff (PDF)

Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3876-3883

2012

Volltextzugriff (PDF)

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell–depleted stem cell transplantation

Blood, 2015-01, Vol.125 (5), p.784-792

2015

Volltextzugriff (PDF)

Bibliometric evaluation of Forensic Science International as a scholarly journal within the subject category legal medicine

Forensic science international. Synergy, 2023, Vol.7, p.100438-100438, Article 100438

Jones, Alan Wayne

2023

Volltextzugriff (PDF)

Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

Haematologica (Roma), 2023-03, Vol.108 (3), p.747-760

2023

Volltextzugriff (PDF)

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

Haematologica (Roma), 2010-11, Vol.95 (11), p.1873-1879

2010

Volltextzugriff (PDF)

Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia

Pediatric blood & cancer, 2018-09, Vol.65 (9), p.e27265-n/a

2018

Volltextzugriff (PDF)

Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies

PloS one, 2012-12, Vol.7 (12), p.e52655

2012

Volltextzugriff (PDF)

Pediatric Melanoma: Risk Factor and Survival Analysis of the Surveillance, Epidemiology and End Results Database

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4735-4741

2005

Volltextzugriff (PDF)

Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial

Clinical cancer research, 2010-03, Vol.16 (6), p.1894-1903

2010

Volltextzugriff (PDF)

Enhancing pediatric access to cell and gene therapies

Nature medicine, 2024-07, Vol.30 (7), p.1836-1846

2024

Volltextzugriff (PDF)

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

Haematologica (Roma), 2022-10, Vol.107 (10), p.2295-2303

2022

Volltextzugriff (PDF)

1 – 25 von 2.344

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.837)
Mit Volltextzugriff
(1.844)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.214)
Life Sciences & Biomedicine
(951)
Humans
(692)
Male
(423)
Female
(372)
Biological And Medical Sciences
(354)
Animals
(289)
Medical Sciences
(278)
Adult
(249)
Physical Sciences
(225)
Middle Aged
(210)
Mice
(134)
Aged
(132)
Adolescent
(127)
Child
(105)
Technology
(105)
Chemistry
(102)
Fundamental And Applied Biological Sciences. Psychology
(100)
Physics
(93)
Hematology
(84)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(929)
EZB Electronic Journals Library
(870)
Ingenta
(828)
Journals@Ovid Full Text
(702)
NUS Single-Journal Subscriptions
(613)
Elsevier ScienceDirect Journals Complete
(408)
IngentaConnect Journals
(387)
Wiley-Blackwell Journals
(290)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(271)
Wiley Online Library
(204)
JSTOR All Journals
(197)
Taylor & Francis Current Content Access
(152)
Taylor & Francis Journals
(148)
SpringerLink Journals - AutoHoldings
(113)
ProQuest Dissertations & Theses A&I
(110)
Ebook Central Perpetual and DDA
(104)
eBooks on EBSCOhost
(102)
Oxford Journals
(100)
Taylor & Francis Online
(88)
EBSCOhost Business Source Ultimate
(76)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

CAR T-cell product performance in haematological malignancies before and after marketing authorisation

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor

Immunogenicity of CAR T cells in cancer therapy

Immunotoxins for leukemia

Characterization of CD22 expression in acute lymphoblastic leukemia

Biological roles and potential applications of immune cell-derived extracellular vesicles

Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells

Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates

Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell–depleted stem cell transplantation

Bibliometric evaluation of Forensic Science International as a scholarly journal within the subject category legal medicine

Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study

Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies

Pediatric Melanoma: Risk Factor and Survival Analysis of the Surveillance, Epidemiology and End Results Database

Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial

Enhancing pediatric access to cell and gene therapies

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

Suchergebnisse filtern